Similar articles for PMID: 27740868

Year	Number of Results
1938	1
1998	1
2002	1
2004	1
2005	2
2006	1
2007	7
2008	10
2009	2
2010	4
2011	6
2012	15
2013	15
2014	22
2015	25
2016	29
2017	43
2018	55
2019	34
2020	36
2021	33
2022	13
2023	5
2024	0

1

Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.

Donnez J, Donnez O, Dolmans MM. Donnez J, et al. Expert Opin Drug Saf. 2016 Dec;15(12):1679-1686. doi: 10.1080/14740338.2016.1248943. Epub 2016 Nov 2. Expert Opin Drug Saf. 2016. PMID: 27740868 Review.

2

Selective progesterone receptor modulators (SPRMs) for uterine fibroids.

Murji A, Whitaker L, Chow TL, Sobel ML. Murji A, et al. Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD010770. doi: 10.1002/14651858.CD010770.pub2. Cochrane Database Syst Rev. 2017. PMID: 28444736 Free PMC article. Review.

3

Vilaprisan for treating uterine fibroids.

Melis GB, Neri M, Piras B, Paoletti AM, Ajossa S, Pilloni M, Marotto MF, Corda V, Saba A, Giancane E, Mais V. Melis GB, et al. Expert Opin Investig Drugs. 2018 May;27(5):497-505. doi: 10.1080/13543784.2018.1471134. Epub 2018 May 7. Expert Opin Investig Drugs. 2018. PMID: 29718788 Review.

4

Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids.

Tafi E, Scala C, Leone Roberti Maggiore U, Bizzarri N, Candiani M, Venturini PL, Ferrero S. Tafi E, et al. Expert Opin Drug Saf. 2015 Jun;14(6):965-77. doi: 10.1517/14740338.2015.1021773. Epub 2015 Mar 14. Expert Opin Drug Saf. 2015. PMID: 25772793 Review.

5

[Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].

Szamatowicz M, Kotarski J. Szamatowicz M, et al. Ginekol Pol. 2013 Mar;84(3):219-22. doi: 10.17772/gp/1567. Ginekol Pol. 2013. PMID: 23700851 Review. Polish.

6

Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids.

Ferrero S, Vellone VG, Barra F. Ferrero S, et al. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):107-116. doi: 10.1080/17425255.2018.1417389. Epub 2017 Dec 20. Expert Opin Drug Metab Toxicol. 2018. PMID: 29250979 Review.

7

Emerging treatment options for uterine fibroids.

Donnez J, Arriagada P, Donnez O, Dolmans MM. Donnez J, et al. Expert Opin Emerg Drugs. 2018 Mar;23(1):17-23. doi: 10.1080/14728214.2018.1446943. Epub 2018 Mar 12. Expert Opin Emerg Drugs. 2018. PMID: 29486606 Review.

8

The place of selective progesterone receptor modulators in myoma therapy.

Donnez J, Donnez O, Courtoy GE, Dolmans MM. Donnez J, et al. Minerva Ginecol. 2016 Jun;68(3):313-20. Epub 2016 Mar 1. Minerva Ginecol. 2016. PMID: 26930390 Review.

9

Ulipristal acetate for uterine fibroid-related symptoms.

Puchar A, Luton D, Koskas M. Puchar A, et al. Drugs Today (Barc). 2015 Nov;51(11):661-7. doi: 10.1358/dot.2015.51.11.2413469. Drugs Today (Barc). 2015. PMID: 26744741 Review.

10

Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.

Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E. Barlow DH, et al. Hum Reprod. 2014 Mar;29(3):480-9. doi: 10.1093/humrep/det467. Epub 2014 Jan 23. Hum Reprod. 2014. PMID: 24457604 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

306 results

Results by year